View selected publications citing GeneCopoeia's Antibody products from the recent literature
2019
- Mizui, T., et al. (2019). Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia. Journal of Psychiatric Research doi: 10.1016/j.jpsychires.2019.03.024 [anti-human proBDNF antibody]
- Benicky, J., et a.. (2019).N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures. The Journal of Biological Chemistry doi: 10.1074/jbc.RA119.009989 [anti-human proBDNF antibody]
2017
- Yang, B., et al. (2017). Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis. Translational Psychiatry doi: 10.1038/tp.2017.95 [anti-human proBDNF antibody]
- Zhang, S., et al. (2017). Inhibition of BDNF production by MPP+ through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model. Neuorscience Letters doi: 10.1016/j.neulet.2017.10.014 [anti-human proBDNF antibody]